Article
Age-dependent clinical, molecular, and prognostic differences in patients with AML: a retrospective study.
Hematology (Amsterdam, Netherlands) - 1 Dec 2026
Liu Hong, Li Zhi, Ma Jingjing, Shi Yuye, Tao Shandong, Chen Yue, Ji Tingting, Su Yang, Chen Qiuni, Wang Chunling, Yu Liang
Abstract excerpt
OBJECTIVES: This study aimed to compare clinical, and molecular features between acute myeloid leukemia (AML) patients aged <50 and ≥50 years, while also assessing their respective treatment outcomes and prognostic factors. METHODS: We conducted a retrospective analysis of clinical data from AML patients treated at our institution between October 2015 and June 2021, supplemented by data extracted from the SEER...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
